2nd Announcement

INTERNATIONAL ACADEMYFOR ADVANCED ONCOLOGY

IAAO
2024
Innovative Initiatives for
Challenging Treatments
2024 July 26 (Fri) 13:00 – 18:30
July 27 (Sat) 9:00 – 15:00@ Toranomon Hills ForumInnovative Initiatives for
Challenging Treatments
DAY 1: Friday, July 26, 2024 13:00 – 18:30 On-site in Tokyo
Opening Remarks
13:00

Motoo Ueno, President, Chugai Foundation for Innovative Drug Discovery Science (C-FINDs)

1. Keynote Lecture
13:05

One Drug is Not EnoughSpeaker: Bruce A. Chabner, MD, Professor, Harvard Medical School, USA
Chair: Kiyohiko Hatake, MD, PhD, Professor, Akasaka Sanno Medical Center, Japan

2. New Insights in Anti-Tumor Immunotherapy
13:25

Personalized Cancer Vaccines: Encouraging Results and New Opportunities
Speaker: Catherine J. Wu, MD, Professor, Harvard Medical School, USA
Chair: Hiroyoshi Nishikawa, MD, PhD, Professor, Nagoya University, Japan

14:05

Spatial Organization of the Immune Response in Cancer
Speaker: Nir Hacohen, PhD, Professor, Harvard Medical School, USA
Chair: Hiroyoshi Nishikawa, MD, PhD, Professor, Nagoya University, Japan

14:45

Break

3. Novel Treatment Strategies in Brain Tumor
15:00
CAR T Cell Therapy for Glioblastoma: Clinical Insights for Response and Resistance
Speaker: Christine Brown, PhD, Professor, City of Hope, USA
Chair: Hitoshi Nakagama, MD, D.M.Sc, President, National Cancer Center, Japan
15:40

16:20

17:00

A Blood Test for Brain Tumors: How Microfluidics Can Enable Insight into Patient Response
Speaker: Shannon Stott, PhD, Associate Professor, Harvard Medical School
Chair: Hitoshi Nakagama, MD, D.M.Sc, President, National Cancer Center, Japan
Genetic Alterations and Cell-of-Origin in Medulloblastoma
Speaker: Hiromichi Suzuki, MD, PhD, Chief, National Cancer Center, JapanChair: Hitoshi Nakagama, MD, D.M.Sc, President, National Cancer Center, Japan
Break

4. Innovative Research in Microbiome
17:10

Host-Microbiome Interaction in Health and Disease
Speaker: Eran Elinav, MD, PhD, Professor, Weizmann Institute of Science, Israel
Chair: Naoko Ohtani, MD, PhD, Professor, Osaka Metropolitan University, Japan

17:50

Targeting the Microbiota for Cancer Immunotherapy
Speaker: Giorgio Trinchieri, MD, Chief, National Cancer Institute, USA
Chair: Naoko Ohtani, MD, PhD, Professor, Osaka Metropolitan University, Japan

18:30

Announcement (C-FINDs)

19:00

Networking Dinner

Official language: EnglishDress code: Business CasualDAY 2: Saturday, July 27, 2024 9:00 – 15:00 On-site in Tokyo
5. Keynote Lecture
9:00

New Immunotherapy Approaches for Microsatellite Stable (MSS) Colorectal Cancer
Speaker: Josep Tabernero, MD, PhD, Director, Vall d’Hebron Institute of Oncology, Spain
Chair: Chikashi Ishioka, MD, PhD, Director, JR Sendai Hospital, Japan

Break
9:40
6. Leverage of Real World Data in EU, US and Japan
9:55

Clinical Cancer Genomics: Informing Real World Clinical Oncology and Driving Further Treatment
Advances and Biological Insights
Speaker: Marc Ladanyi, MD, Chief, Memorial Sloan Kettering Cancer Center, USA
Chair: Hiroyuki Mano, MD, PhD, Director, National Cancer Center Research Institute, Japan

10:35

Leverage of Real World Data in France and EU
Speaker: Axelle Menu-Branthomme, MD, Medical Expert, Health Data Hub, France
Chair: Hiroyuki Mano, MD, PhD, Director, National Cancer Center Research Institute, Japan

11:15

Real-World Evidence Generated from C-CAT’s Big Data
Speaker: Takashi Kohno, PhD, Chief, National Cancer Center, Japan
Chair: Hiroyuki Mano, MD, PhD, Director, National Cancer Center Research Institute, Japan

11:55

Lunch/ Advisory Board Meeting

7. Breakthrough Technology Session: Protein Degrader, Precision Diagnosis, Efficacy Prediction
12:45

Targeted Protein Degradation Approaches for Cancer Drug Discovery
Speaker: Zoran Rankovic, PhD, Professor, The Institute of Cancer Research, UK
Chair: Masakazu Toi, MD, PhD, Director, Tokyo Metropolitan Komagome Hospital, Japan

13:25

Multimodal and Generative AI for Pathology
Speaker: Faisal Mahmood, PhD, Associate Professor, Harvard Medical School, USA
Chair: Masakazu Toi, MD, PhD, Director, Tokyo Metropolitan Komagome Hospital, Japan

14:05

Liquid Biopsies for Cancer Detection and Characterization
Speaker: Maximilian Diehn, MD, PhD, Professor, Stanford University, USA
Chair: Masakazu Toi, MD, PhD, Director, Tokyo Metropolitan Komagome Hospital, Japan

Closing Remarks
14:45

Hiroyuki Mano, MD, PhD, Director, National Cancer Center Research Institute, Japan

Next Forum Information

IAAO 2025
Date: Friday August 1 – Saturday August 2, 2025
Venue: Toranomon Hills Forum, Tokyo

Access Map
Venue: Toranomon Hills Forum
5F, Toranomon Hills Mori Tower, 1 Chome-23-1 Toranomon,
Minato City, Tokyo 105-6390

11-minute walk from the
Karasumoriguchi
Exit of Shimbashi Stn.
Subway:Hibiya Line
Toranomon Hills Stn
1. B1 Exit
2. A1b Exit
Ginza Line
Toranomon Stn
1. B1 Exit
2. B4 Exit

Chugai Foundation for Innovative Drug Discovery Science

Location: Sumitomofudosan Nihonbashi-Honcho Bldg., 9F, 4-11-5
Nihonbashi-honcho, Chuo-ku, Tokyo 103-0023, JAPANTEL:+81-3-5843-6733
URL:
https://c-finds.com